ECOWAS Essential Medicines & Vaccines
WA-MRH
Lang
English
French
Portuguese
ECOWAS Essential Medicines & Vaccines
WA-MRH
About Us
Overview - History & Mission
What We Do
Benefits
Success Stories
WA-MRH
Partners
Member Login
Communities of Practice
Member States
Benin
Burkina Faso
Cabo Verde
Cote d'Ivoire
The Gambia
Ghana
Guinea
Guinea-Bissau
Liberia
Mali
Niger
Nigeria
Senegal
Sierra Leone
Togo
ECOWAS
Regional Basket
Events & News
News media
Upcoming Events
Photo Gallery
Video Gallery
Document Center
Guidelines
SOPs
Manuals
Templates
Library
Publications
|
Lang
English
French
Portuguese
We use cookies, just to track visits to our website, we store no personal details.
Learn More
Accept
Regional Joint Assessment Procedure for Medicine Registration and Marketing Authorization of Medicinal Products
Author:
WAHO
Category:
Medical Products Dossier Evaluation and Registration
Language:
English
Description
This is a procedure for joint assessment by the Expert Working Group on Medical Products Dossier Assessment of the selected medicinal products, inspection of their respective manufacturing site(s) followed by Steering Committee approval of jointly accepted medicinal products.
Abstract
Joint Medicines Dossier Evaluation Procedure This is a procedure for joint assessment by the Expert Working Group on Medical Products Dossier Assessment of the selected medicinal products, inspection of their respective manufacturing site(s) followed by Steering Committee approval of jointly accepted medicinal products. If the assessment of medicinal products dossier is successfully completed and jointly accepted, the ECOWAS Member Sates NMRAs will grant marketing authorization within maximum of three (3) months from the date of joint acceptance. The Marketing Authorization Holder (MAH) can begin to make the medicine available to patients and healthcare professionals in ECOWAS Member States where marketing authorization has been granted.
Download PDF
Back To List
Feedback
×
Submit a feedback
Contact Email
Feedback Title
Feedback
Submit